Kbp Biosciences Stock

kbpbiosciences.comHealthcare / BioTech & PharmaFounded: 2007Funding to Date: $76MM

KBP is a biotechnology company focused on organ, antimicrobial, and immunology research.

Register To Buy and Sell Shares

For more details on financing and valuation for Kbp Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Kbp Biosciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Kbp Biosciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Robert Segal MD
Deputy Chief Medical Officer
Fred Yang Ph.D
Chief Development Officer
Vince Benn Ph.D
Vice President, Regulatory & Medical Affairs

Board Members

Benjamin Qiu
Bing Wang Ph.D
Frederick Craves Ph.D
Bay City Capital
Huang Zhenhua Ph.D

Kbp Biosciences’ stock FAQs


Can you buy Kbp Biosciences’ stock?

Kbp Biosciences is not publicly traded on NYSE or NASDAQ in the U.S. To buy Kbp Biosciences’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Kbp Biosciences’ stock?

Yes, you can sell stock of a private company like Kbp Biosciences. Forge can help you sell your Kbp Biosciences stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Kbp Biosciences’ stock price?

Kbp Biosciences is a privately held company and therefore does not have a public stock price. However, you may access Kbp Biosciences’ private market stock price with Forge Data.

What is Kbp Biosciences’ stock ticker symbol?

Kbp Biosciences does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

China: KBP Biosciences secures $76m Series A, launches global HQ in US

Clinical-stage biotechnology firm KBP Biosciences has secured a $76 million Series A financing round led by Advantech Capital and SDIC Venture Capital.

KBP Biosciences Raises $76M in Series A Financing |FinSMEs

KBP Biosciences, a Greater Philadelphia Area and Jinan, China-based private clinical-stage biotechnology company dedicated to the research, development and commercialization of innovative medicines in areas of unmet medical need, closed a $76m Series A financing. The round was co-led by Advantech Capital and SDIC Venture Capital, with participation from Sangel Capital, Ping An Ventures, Bay …
Updated on: Jun 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.